MCID: INT007
MIFTS: 50

Intermediate Coronary Syndrome

Categories: Cardiovascular diseases, Cancer diseases

Aliases & Classifications for Intermediate Coronary Syndrome

MalaCards integrated aliases for Intermediate Coronary Syndrome:

Name: Intermediate Coronary Syndrome 12 14
Angina, Unstable 42 69
Myocardial Preinfarction Syndrome 69
Carcinoma in Situ of Trachea 69
Tracheal Carcinoma in Situ 12
Anginal Chest Pain at Rest 12
Impending Infarction 12
Preinfarction Angina 12
Worsening Angina 12
Unstable Angina 12
Angina at Rest 12

Classifications:



Summaries for Intermediate Coronary Syndrome

MalaCards based summary : Intermediate Coronary Syndrome, also known as angina, unstable, is related to angina pectoris and myocardial infarction, and has symptoms including angina pectoris, coughing and dyspnea. An important gene associated with Intermediate Coronary Syndrome is ITGA2B (Integrin Subunit Alpha 2b), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Ticagrelor and Ticlopidine have been mentioned in the context of this disorder. Affiliated tissues include heart, testes and kidney, and related phenotypes are cardiovascular system and homeostasis/metabolism

Related Diseases for Intermediate Coronary Syndrome

Diseases related to Intermediate Coronary Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 154)
id Related Disease Score Top Affiliating Genes
1 angina pectoris 27.1 ACE CRP F3 IL6 PLAT SELP
2 myocardial infarction 22.5 ACE CRP F3 IL6 ITGA2B MB
3 prinzmetal's variant angina 11.5
4 coronary artery disease 11.4
5 trachea carcinoma in situ 11.1
6 global developmental delay-osteopenia-ectodermal defect syndrome 10.8 TNNI3 TNNT2
7 sagittal sinus thrombosis 10.6 F3 SERPINC1
8 fragile x syndrome type 2 10.6 F3 SERPINC1
9 arteriovenous malformation 10.6 PIK3C2A TNNI3
10 primary hyperoxaluria 10.6 ACE SERPINC1
11 silent myocardial infarction 10.6 PF4 PLG
12 collagenous gastritis 10.6 PF4 SERPINC1
13 testicular gonadoblastoma 10.5 F3 SERPINC1
14 essential thrombocythemia 10.5 F3 ITGA2B SERPINC1
15 sulfhemoglobinemia 10.5 F3 PLG
16 hypertrophic elongation of cervix 10.5 ACE CRP ITGA2B
17 female breast upper-outer quadrant cancer 10.5 SERPINC1 TNNI3 TNNT2
18 congenital syphilis 10.5 CRP F3 SERPINC1
19 oesophagostomiasis 10.5 TNNI3 TNNT1 TNNT2
20 hyperthyroidism 10.5 F3 PLG
21 adams-oliver syndrome 5 10.5 ACE CRP TNNI3
22 visual snow syndrome 10.4 MB PIK3C2A
23 autoimmune disease of skin and connective tissue 10.4 ACE TNNI3 TNNT2
24 thrombomodulin anomalies, familial 10.4 F3 ITGA2B SELP
25 craniosynostosis 7 10.4 ACE CRP TNNI3
26 venezuelan hemorrhagic fever 10.4 PLAT SERPINC1
27 american histoplasmosis 10.4 PF4 SELP SERPINC1
28 endometrial type cervical adenomyoma 10.4 MB PIK3C2A
29 bleeding disorder, platelet-type, 16, autosomal dominant 10.4 F3 ITGA2B SELP
30 myopathy, distal, tateyama type 10.4 MB PIK3C2A
31 iron metabolism disease 10.4 ACE CRP SELP
32 velocardiofacial syndrome 10.4 MB PIK3C2A
33 collagenous colitis 10.4 ACE SERPINC1
34 hereditary amyloidosis 10.4 F3 SELP SERPINC1
35 pyrimidine metabolic disorder 10.4 CRP PIK3C2A TNNI3
36 rocky mountain spotted fever 10.3 CRP SERPINC1
37 arcus senilis 10.3 CRP F3 PLG
38 lin-gettig syndrome 10.3 PLAT PLG
39 perichondritis of auricle 10.3 F3 ITGA2B PF4 SERPINC1
40 cardiocranial syndrome 10.3 CRP PLAT
41 intra-abdominal lymph node mast cell malignancy 10.3 ACE CRP SELP
42 lymphatic system cancer 10.3 F3 PLAT SERPINC1
43 partial sensory epilepsy 10.3 CRP F3 ITGA2B SERPINC1
44 primary polycythemia 10.3 ACE PIK3C2A
45 syndactyly, mesoaxial synostotic, with phalangeal reduction 10.3 PLG SERPINC1
46 psychosexual disorder 10.2 CRP PLAT SELP
47 pyridoxine deficiency anemia 10.2 F3 PLG SERPINC1
48 myiasis 10.2 F3 PLG SERPINC1
49 collagenopathy type 2 alpha 1 10.2 CRP IL6
50 rectum neuroendocrine neoplasm 10.2 F3 PLG SERPINC1

Comorbidity relations with Intermediate Coronary Syndrome via Phenotypic Disease Network (PDN): (show top 50) (show all 103)


Acquired Thrombocytopenia Active Peptic Ulcer Disease
Acute Cystitis Acute Kidney Failure
Acute Myocardial Infarction Acute Stress Disorder
Allergic Urticaria Anthracosis
Anxiety Disorder Aortic Aneurysm
Aortic Atherosclerosis Aortic Valve Disease 2
Asbestosis Atrioventricular Block
Atrophic Gastritis Basilar Artery Insufficiency
Benign Essential Hypertension Benign Hypertensive Renal Disease
Benign Paroxysmal Positional Nystagmus Bleeding Disorder, Platelet-Type, 11
Bronchitis Cardiac Arrest
Cardiogenic Shock Cardiomyopathy, Familial Hypertrophic
Cerebrovascular Disease Chronic Kidney Failure
Chronic Myocardial Ischemia Constrictive Pericarditis
Deficiency Anemia Diabetic Polyneuropathy
Diaphragm Disease Dressler's Syndrome
Duodenitis Dyskinesia of Esophagus
Dysthymic Disorder Esophagitis
Familial Atrial Fibrillation First-Degree Atrioventricular Block
Gallbladder Disease Gastroesophageal Reflux
Generalized Atherosclerosis Gout
Heart Conduction Disease Heart Disease
Hemopericardium Hyperlipidemia, Familial Combined
Hyperlipoproteinemia Type Iv Hypertension, Essential
Hypertensive Encephalopathy Hyperuricemia, Pulmonary Hypertension, Renal Failure, and Alkalosis

Graphical network of the top 20 diseases related to Intermediate Coronary Syndrome:



Diseases related to Intermediate Coronary Syndrome

Symptoms & Phenotypes for Intermediate Coronary Syndrome

UMLS symptoms related to Intermediate Coronary Syndrome:


angina pectoris, coughing, dyspnea, hemoptysis, hoarseness

MGI Mouse Phenotypes related to Intermediate Coronary Syndrome:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.22 ACE CRP F3 IL6 ITGA2B MB
2 homeostasis/metabolism MP:0005376 10.17 ACE CRP F3 IL6 ITGA2B MB
3 hematopoietic system MP:0005397 10.15 ACE F3 IL6 ITGA2B MB P2RY12
4 immune system MP:0005387 9.96 F3 IL6 ITGA2B PIK3C2A PLAT PLG
5 mortality/aging MP:0010768 9.9 PLG SELP SERPINC1 TNNI3 TNNT2 ACE
6 muscle MP:0005369 9.5 F3 IL6 MB PLAT TNNI3 TNNT1
7 respiratory system MP:0005388 9.17 F3 IL6 MB PLAT PLG SELP

Drugs & Therapeutics for Intermediate Coronary Syndrome

Drugs for Intermediate Coronary Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 388)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1 274693-27-5 9871419
2
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1 55142-85-3 5472
3
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2 33069-62-4 36314
4
Pravastatin Approved Phase 4,Phase 3 81093-37-0 54687
5
Everolimus Approved Phase 4,Phase 2,Phase 3 159351-69-6 6442177
6
Sirolimus Approved, Investigational Phase 4,Phase 2,Phase 3 53123-88-9 5284616 6436030 46835353
7
Citalopram Approved Phase 4,Phase 1,Phase 2 59729-33-8 2771
8
Udenafil Approved, Investigational Phase 4 268203-93-6 6918523
9
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
10
Colchicine Approved Phase 4,Phase 3 64-86-8 6167 2833
11
Etanercept Approved, Investigational Phase 4 185243-69-0
12
Menthol Approved Phase 4 2216-51-5 16666
13
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
14
Pantoprazole Approved Phase 4 102625-70-7 4679
15
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2 9005-49-6 772 46507594
16
Isosorbide Dinitrate Approved Phase 4,Early Phase 1 87-33-2 6883
17
Nitric Oxide Approved Phase 4,Early Phase 1 10102-43-9 145068
18
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 22916-47-8 4189
19
Eptifibatide Approved, Investigational Phase 4,Phase 3,Phase 2 188627-80-7 123610
20
Pitavastatin Approved Phase 4 147511-69-1, 147526-32-7 6366718 5282452
21
Rivaroxaban Approved Phase 4,Phase 3,Phase 2 366789-02-8
22
Tirofiban Approved Phase 4,Phase 3,Phase 2 144494-65-5 60947
23
Pioglitazone Approved, Investigational Phase 4,Phase 3 111025-46-8 4829
24
Bupropion Approved Phase 4,Phase 3,Phase 1,Phase 2 34841-39-9, 34911-55-2 444
25
Dopamine Approved Phase 4,Phase 3,Phase 1,Phase 2 51-61-6, 62-31-7 681
26
Lornoxicam Approved Phase 4 70374-39-9 5282204
27
Piroxicam Approved, Investigational Phase 4 36322-90-4 5280452 54676228
28
Acarbose Approved, Investigational Phase 4 56180-94-0 441184
29
Chromium Approved Phase 4,Phase 2,Phase 3 7440-47-3 27668
30
Fluvastatin Approved Phase 4,Phase 3 93957-54-1 1548972
31
Simvastatin Approved Phase 4,Phase 2,Phase 3 79902-63-9 54454
32
Bisoprolol Approved Phase 4 66722-44-9 2405
33
Ramipril Approved Phase 4 87333-19-5 5362129
34
Saxagliptin Approved Phase 4 361442-04-8 11243969
35
Cilostazol Approved Phase 4 73963-72-1 2754
36
Glipizide Approved Phase 4 29094-61-9 3478
37
Metformin Approved Phase 4 657-24-9 14219 4091
38
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
39
Telmisartan Approved, Investigational Phase 4 144701-48-4 65999
40
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
41 Racepinephrine Approved Phase 4
42
Adenosine Approved, Investigational Phase 4,Phase 2,Phase 3 58-61-7 60961
43
Phenprocoumon Approved Phase 4 435-97-2 9908 54680692
44
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2 128270-60-0 16129704
45
Apixaban Approved Phase 4,Phase 3,Phase 2 503612-47-3 10182969
46
Amlodipine Approved Phase 4 88150-42-9 2162
47
Zinc Approved Phase 4 7440-66-6 32051 23994
48
Allopurinol Approved Phase 4,Phase 3 315-30-0 2094
49
Morphine Approved, Investigational Phase 4 57-27-2 5288826
50
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596

Interventional clinical trials:

(show top 50) (show all 559)

id Name Status NCT ID Phase Drugs
1 Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome Unknown status NCT01372839 Phase 4 Atorvastatin;Statin
2 Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome Unknown status NCT02037412 Phase 4 Ticagrelor;Clopidogrel
3 Small Coronary Artery Treated by TAXUS Liberté Registry in Japan Unknown status NCT00955214 Phase 4
4 Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes Unknown status NCT02126202 Phase 4
5 Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study Unknown status NCT00688922 Phase 4 Pravastatin
6 Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS Unknown status NCT01543373 Phase 4
7 Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor . Unknown status NCT02032303 Phase 4 Ticagrelor loading;Prasugrel loading
8 Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel Unknown status NCT02032290 Phase 4 ticagrelor loading;Clopidogrel loading
9 DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome Unknown status NCT00140257 Phase 4 Escitalopram
10 A Trial to Evaluate Efficacy of Heart-protecting Musk Pill Unknown status NCT01897805 Phase 4 Heart-protecting Musk Pill;Placebo
11 Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome Unknown status NCT00815100 Phase 4 Ivabradine;Placebo
12 Understanding of Chest Pain in Microvascular Disease Proved by Cardiac Magnetic Resonance Image Unknown status NCT01769482 Phase 4 Udenafil;placebo
13 The Canadian Prevention of Renal and Cardiovascular Endpoints Trial Unknown status NCT00231803 Phase 4
14 The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial Unknown status NCT00724724 Phase 4 Butylphthalide Soft Capsules;Aspirin
15 Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes Unknown status NCT00222352 Phase 4
16 Colchicine for Acute Coronary Syndromes Unknown status NCT01906749 Phase 4 Colchicine;Placebo
17 Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction Unknown status NCT01372930 Phase 4 Etanercept;saline
18 Revascularization in Heart Failure Trial – REHEAT 2 Unknown status NCT00388245 Phase 4
19 HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study) Unknown status NCT00106886 Phase 4 Folic acid, vitamin B6 and B12 or placebo
20 CT Coronary Angiogram Versus Traditional Care in Emergency Department Assessment of Potential ACS Unknown status NCT00933400 Phase 4
21 Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism Unknown status NCT02316743 Phase 4 Levothyroxine supplementation
22 The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel Unknown status NCT01365221 Phase 4 Prasugrel;Prasugrel
23 "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER- Unknown status NCT02028234 Phase 4 Pantoprazole,;Omeprazole
24 Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy Unknown status NCT02049762 Phase 4 Aspirin
25 LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients Unknown status NCT02077257 Phase 4 Rosuvastatin
26 Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study Completed NCT02612116 Phase 4 Pulverized ticagrelor sublingually;Pulverized ticagrelor orally;Integral ticagrelor
27 Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Rapid Bedside cTnl on Outcome. Completed NCT00276432 Phase 4
28 Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction Completed NCT00627744 Phase 4 Sitagliptin
29 Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS) Completed NCT00790907 Phase 4 fondaparinux background and standard dose UFH;Fondaparinux background and low dose heparin;Open label fondaparinux
30 Protective Effect of EPA on Cardiovascular Events Completed NCT00231738 Phase 4 Eicosapentaenoic acid ethyl ester(EPADEL Capsule 300 TM)
31 Conservative Non-Invasive Versus Routine Invasive Management in Coronary Artery Bypass Surgery Patients With Non ST Elevation Elevation Acute Coronary Syndrome Completed NCT01895751 Phase 4
32 Aspirin Non-responsiveness and Clopidogrel Endpoint Trial. Completed NCT00222261 Phase 4 aspirin;clopidogrel
33 The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT) Completed NCT01331967 Phase 4 Pioglitazone
34 A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies Completed NCT00566774 Phase 4
35 Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease Completed NCT00181818 Phase 4 bupropion SR (sustained-release)
36 Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome Completed NCT00997750 Phase 4 Lornoxicam
37 Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY) Completed NCT00295191 Phase 4
38 Resistance to Aspirin and/or Clopidogrel Among Patients With PAD. Completed NCT00262561 Phase 4 Aspirin
39 Comparison of Post-dilution On-line Hemodiafiltration and Hemodialysis Completed NCT00411177 Phase 4
40 Acarbose Cardiovascular Evaluation Trial Completed NCT00829660 Phase 4 Acarbose;Matching Placebo
41 Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease Completed NCT01637012 Phase 4
42 The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT) Completed NCT01341730 Phase 4 Atorvastatin 20mg;Atorvastatin 20 mg + Pioglitazone 30 mg
43 DANish Multicenter STENT Trial Completed NCT00139802 Phase 4
44 Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI Completed NCT01293097 Phase 4 Atorvastatin;Statin
45 Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression Completed NCT01212900 Phase 4 Statin Drugs
46 Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease Completed NCT03011775 Phase 4 Pioglitazone 15 mg Tablet;Isosorbide Dinitrate 10Mg Tablet;Acetylsalicylic Acid 75Mg Tablet;Bisoprolol Fumarate 2.5 MG Oral Tablet;Rosuvastatin Calcium 20 MG Oral Tablet;ramipril 5 MG
47 Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications Completed NCT01107886 Phase 4 Saxagliptin;Placebo
48 Randomized Trial of Immediate Versus Early and Selective Invasive Percutaneous Coronary Intervention in NSTEMI Completed NCT00402675 Phase 4
49 Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke Completed NCT00147602 Phase 4 atorvastatin
50 The Use of Cilostazol in Patients With Diabetic Nephropathy Completed NCT00272831 Phase 4 Cilostazol;Placebo

Search NIH Clinical Center for Intermediate Coronary Syndrome

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: angina, unstable

Genetic Tests for Intermediate Coronary Syndrome

Anatomical Context for Intermediate Coronary Syndrome

MalaCards organs/tissues related to Intermediate Coronary Syndrome:

39
Heart, Testes, Kidney, Endothelial, Lung, Liver, Brain

Publications for Intermediate Coronary Syndrome

Articles related to Intermediate Coronary Syndrome:

(show all 22)
id Title Authors Year
1
A prospective study of an algorithm using cardiac troponin I and myoglobin as adjuncts in the diagnosis of acute myocardial infarction and intermediate coronary syndromes in a veteran's hospital. ( 11129678 )
2000
2
Management of intermediate coronary syndrome: role of conservative treatment, glycoprotein IIb/IIIa receptor inhibitors, and direct intervention. ( 11076127 )
2000
3
Unstable angina pectoris. Platelet behavior and prognosis in progressive angina and intermediate coronary syndrome. ( 2136815 )
1990
4
Atenolol, heparin and the intermediate coronary syndrome. ( 6113419 )
1981
5
Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. ( 6112564 )
1981
6
The intermediate coronary syndrome. ( 6971456 )
1981
7
Pathophysiologic significance of S-T and T wave abnormalities in patients with the intermediate coronary syndrome. ( 299974 )
1977
8
Long-term follow-up in patients receiving emergency revascularization for intermediate coronary syndrome. ( 4600203 )
1974
9
SURGICAL MANAGEMENT OF THE INTERMEDIATE CORONARY SYNDROME. ( 15215960 )
1974
10
Editorial: Intermediate coronary syndrome. ( 4148257 )
1973
11
Letter: Intermediate coronary syndrome. ( 4752330 )
1973
12
Bradycardia in intermediate coronary syndrome. ( 4723578 )
1973
13
The intermediate coronary syndrome: clinical, angiographic and therapeutic aspects. ( 4144755 )
1973
14
The natural history of intermediate coronary syndrome. ( 4721961 )
1973
15
Early diagnosis of acute myocardial infarction with special reference to the diagnosis of the intermediate coronary syndrome. A clinical study. ( 4586014 )
1972
16
Recognition and management of the intermediate coronary syndrome. ( 6021604 )
1967
17
Diagnosis and management of the intermediate coronary syndrome. A clinical study of 400 cases of the syndrome. ( 5932254 )
1966
18
THE INTERMEDIATE CORONARY SYNDROME. ( 14061336 )
1963
19
Intermediate coronary syndrome. ( 13779654 )
1961
20
Electrocardiographic changes in the intermediate coronary syndrome. II. Location of lesions. ( 13286446 )
1956
21
The intermediate coronary syndrome. ( 13226558 )
1955
22
I. Electrocardiographic changes in the intermediate coronary syndrome. ( 13211952 )
1954

Variations for Intermediate Coronary Syndrome

Expression for Intermediate Coronary Syndrome

Search GEO for disease gene expression data for Intermediate Coronary Syndrome.

Pathways for Intermediate Coronary Syndrome

GO Terms for Intermediate Coronary Syndrome

Cellular components related to Intermediate Coronary Syndrome according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.8 F3 ITGA2B P2RY12 PLAT PLG
2 extracellular space GO:0005615 9.61 ACE CRP F3 IL6 PF4 PLAT
3 external side of plasma membrane GO:0009897 9.55 ACE IL6 ITGA2B P2RY12 SELP
4 platelet alpha granule membrane GO:0031092 9.43 ITGA2B SELP
5 cardiac myofibril GO:0097512 9.32 TNNI3 TNNT2
6 cardiac Troponin complex GO:1990584 9.26 TNNI3 TNNT2
7 troponin complex GO:0005861 8.8 TNNI3 TNNT1 TNNT2
8 extracellular region GO:0005576 10.06 ACE CRP F3 IL6 PF4 PLAT
9 extracellular exosome GO:0070062 10.02 ACE CRP F3 ITGA2B MB PIK3C2A

Biological processes related to Intermediate Coronary Syndrome according to GeneCards Suite gene sharing:

(show all 14)
id Name GO ID Score Top Affiliating Genes
1 platelet activation GO:0030168 9.69 IL6 P2RY12 PF4
2 platelet degranulation GO:0002576 9.62 ITGA2B PF4 PLG SELP
3 fibrinolysis GO:0042730 9.54 PLAT PLG
4 muscle filament sliding GO:0030049 9.54 TNNI3 TNNT1 TNNT2
5 heart contraction GO:0060047 9.49 ACE TNNI3
6 positive regulation of leukocyte migration GO:0002687 9.48 ITGA2B SELP
7 neutrophil mediated immunity GO:0002446 9.46 ACE IL6
8 negative regulation of ATPase activity GO:0032780 9.43 TNNI3 TNNT2
9 negative regulation of lipid storage GO:0010888 9.4 CRP IL6
10 blood coagulation GO:0007596 9.35 F3 P2RY12 PLAT PLG SERPINC1
11 regulation of muscle contraction GO:0006937 9.33 TNNI3 TNNT1 TNNT2
12 slow-twitch skeletal muscle fiber contraction GO:0031444 9.26 MB TNNT1
13 muscle cell cellular homeostasis GO:0046716 9.22 IL6
14 hemostasis GO:0007599 8.92 F3 P2RY12 PLG SERPINC1

Molecular functions related to Intermediate Coronary Syndrome according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 tropomyosin binding GO:0005523 9.16 TNNT1 TNNT2
2 troponin T binding GO:0031014 8.96 TNNI3 TNNT1
3 troponin C binding GO:0030172 8.62 TNNI3 TNNT2

Sources for Intermediate Coronary Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....